VSL Pharmaceuticals, Inc. v. David Starr
| VSL PHARMACEUTICALS, INC., LEADIANT BIOSCIENCES, INC., formerly doing business as Sigma-Tau Pharmaceuticals, Incorporated and ALFASIGMA USA, INC. |
| DAVID STARR, BERNADETTE MAVRIKOS, EDMUND QUIAMBAO, JAMES TETTENHORST, JEREMY HANSEN, KRISTA KARO, ARLENE REED-COSSAIRT, PETER STAVROS and HEATHER FARKAS |
| 25-115 |
| February 12, 2025 |
| U.S. Court of Appeals, Fourth Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 7, 2025. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 45 COURT ORDER filed denying Motion for permission to appeal [ # 2 ]; denying Motion to strike [ # 27 ]. Copies to all parties. [1001748799] [25-115] CH [Entered: 04/07/2025 12:38 PM] |
| Filing 44 Returned mail received from Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst re [ # 7 ] notice requesting response. What action was taken to correct address and re-serve document? not participating; no action taken. [1001746336] [25-115] CH [Entered: 04/01/2025 02:49 PM] |
| Filing 43 Returned mail received from Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst re [ # 7 ] notice requesting response. What action was taken to correct address and re-serve document? not participating; no action taken to reserve document. [1001744378] [25-115] CH [Entered: 03/28/2025 01:19 PM] |
Filing 42
ORDER filed sealing the reply and supplemental appendix. Copies to all parties. [1001741816] [25-115] CH [Entered: 03/25/2025 10:25 AM]
|
| Filing 41 REPLY by Alfasigma USA, Inc., Leadiant Biosciences, Inc. and VSL Pharmaceuticals, Inc. to response [ # 33 ].. [1001741536] [25-115] Andrew Soukup [Entered: 03/24/2025 08:16 PM] |
| Filing 40 CERTIFICATE OF CONFIDENTIALITY (Local Rule 25(c)) by Alfasigma USA, Inc.. Sealing Required: No. Description of document referenced by certificate: Defendants' Sealed Reply in Support of Rule 23(f) Petition and Sealed Supplemental Appendix. [1001741534] [25-115] Andrew Soukup [Entered: 03/24/2025 08:05 PM] |
| Filing 39 SEALED SUPPLEMENTAL APPENDIX VOLUME(S) (court access) by Alfasigma USA, Inc., Leadiant Biosciences, Inc. and VSL Pharmaceuticals, Inc. . Digital media exhibit volume? N. Filed Ex parte: N. [1001741533] [25-115] Andrew Soukup [Entered: 03/24/2025 07:56 PM] |
| Filing 38 SEALED DOCUMENT (court access only) by Alfasigma USA, Inc., Leadiant Biosciences, Inc. and VSL Pharmaceuticals, Inc.. Document type: REPLY . Date and manner of service: 03/24/2025 US mail. Filed Ex parte: N. [1001741532] [25-115] Andrew Soukup [Entered: 03/24/2025 07:52 PM] |
| Filing 37 RESPONSE/ANSWER by Alfasigma USA, Inc., Leadiant Biosciences, Inc. and VSL Pharmaceuticals, Inc. to Motion [ # 27 ], notice requesting response [ # 29 ]. [1001739957] [25-115] Andrew Soukup [Entered: 03/20/2025 06:37 PM] |
|
Filing 36
ORDER filed sealing response. Copies to all parties. [1001739839] [25-115] CH [Entered: 03/20/2025 03:23 PM]
|
| Filing 35 CERTIFICATE OF CONFIDENTIALITY (Local Rule 25(c)) by Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst. Sealing Required: Yes. Description of document referenced by certificate: Respondents' Answer to Petitioners' Petition for Permission to Appeal. [1001739745] [25-115] Jeffrey Gavenman [Entered: 03/20/2025 01:50 PM] |
| Filing 34 SEALED DOCUMENT (court access only) by Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst. Document type: RESPONSE . Date and manner of service: 03/20/2025 ecf. Filed Ex parte: N. [1001739743] [25-115] Jeffrey Gavenman [Entered: 03/20/2025 01:49 PM] |
| Filing 33 Redacted RESPONSE/ANSWER by Heather Farkas, Jeremy Hansen, Bernadette Mavrikos, Edmund Quiambao, Krista Karo, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst to Motion [ # 2 ]. Nature of response: in opposition. [1001739741] [25-115] Jeffrey Gavenman [Entered: 03/20/2025 01:41 PM] |
| Filing 32 NOTICE by Alfasigma USA, Inc. that a reply will be filed.. [1001738819] [25-115] Andrew Soukup [Entered: 03/18/2025 06:03 PM] |
| Filing 31 APPEARANCE OF COUNSEL by Andrew Soukup for Alfasigma USA, Inc.. [1001738279] [25-115] Andrew Soukup [Entered: 03/18/2025 10:08 AM] |
| Filing 30 Docket correction requested from Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst re: sealed document - Response. [1001738099] [25-115] CH [Entered: 03/17/2025 05:17 PM] |
| Filing 29 NOTICE ISSUED to Alfasigma USA, Inc., Leadiant Biosciences, Inc. and VSL Pharmaceuticals, Inc. requesting response to Motion to strike [ # 27 ]. Response due: 03/20/2025.[1001738094].. [25-115] CH [Entered: 03/17/2025 05:11 PM] |
| Filing 28 CERTIFICATE OF CONFIDENTIALITY (Local Rule 25(c)) by Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst. Sealing Required: Yes. Description of document referenced by certificate: Response to Petition for Permission to Appeal. [1001738003] [25-115] Jeffrey Gavenman [Entered: 03/17/2025 04:18 PM] |
| Filing 27 MOTION by Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst to strike appendix.. Date and method of service: 03/17/2025 ecf. [1001737995] [25-115] Jeffrey Gavenman [Entered: 03/17/2025 04:17 PM] |
| Filing 26 (ENTRY RESTRICTED) SEALED DOCUMENT (court access only) by Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst. Document type: RESPONSE . Date and manner of service: 03/17/2025 hand delivery. Filed Ex parte: N. [1001737982] [25-115]--[Edited 03/20/2025 by CH--see ECF 34] Jeffrey Gavenman [Entered: 03/17/2025 04:14 PM] |
| Filing 25 Attorney Michelle Blauner for James Tettenhorst, Peter Stavros, David Starr, Arlene Reed-Cossairt, Edmund Quiambao, Bernadette Mavrikos, Krista Karo, Jeremy Hansen and Heather Farkas in 25-115, Lydia Ferrarese for Alfasigma USA, Inc. in 25-115, Edward F. Haber for James Tettenhorst, David Starr, Arlene Reed-Cossairt, Edmund Quiambao, Bernadette Mavrikos, Krista Karo and Jeremy Hansen in 25-115, Ian J. McLoughlin for James Tettenhorst, David Starr, Arlene Reed-Cossairt, Edmund Quiambao, Bernadette Mavrikos, Krista Karo and Jeremy Hansen in 25-115, Eric Josh Pelletier for Alfasigma USA, Inc. in 25-115, Andrew James Soukup for Alfasigma USA, Inc. in 25-115, Patrick J. Vallely for James Tettenhorst, Peter Stavros, David Starr, Arlene Reed-Cossairt, Edmund Quiambao, Bernadette Mavrikos, Krista Karo, Jeremy Hansen and Heather Farkas in 25-115, Mark A. Weissman for Alfasigma USA, Inc. in 25-115 terminated from case. Reason for termination: Not participating. [1001727722] [25-115] CH [Entered: 02/27/2025 09:26 AM] |
| Filing 24 APPEARANCE OF COUNSEL by Zachary W. Martin for Leadiant Biosciences, Inc.. [1001723115] [25-115] Zachary Martin [Entered: 02/19/2025 10:23 AM] |
| Filing 23 SEALED DOCUMENT (court access only) by Alfasigma USA, Inc., Leadiant Biosciences, Inc. and VSL Pharmaceuticals, Inc.. Document type: OTHER DOCUMENT - Petition for permission to appeal. Date and manner of service: 02/14/2025 US mail. Filed Ex parte: N. [1001721574] [25-115]--[Edited 03/10/2025 by CH--modify docket text to add title to document type] Andrew Soukup [Entered: 02/14/2025 02:56 PM] |
| Filing 22 APPEARANCE OF COUNSEL by Sarah Harrington for Alfasigma USA, Inc.. [1001721333] [25-115] Sarah Harrington [Entered: 02/14/2025 12:16 PM] |
| Filing 21 Docket correction requested from VSL Pharmaceuticals, Inc.. Re: [ # 18 ] appearance of counsel for Amanda Bird-Johnson.Mailed to: Michelle Blauner, Lydia Ferrarese, Edward Haber, Zachary Martin, Ian McLoughlin, Patrick Vallely, Mark Weissman. [1001721278] [25-115]--[Edited to modify docket text 02/14/2025 by CH] CH [Entered: 02/14/2025 11:27 AM] |
| Filing 20 APPEARANCE OF COUNSEL by John H. Beisner for Leadiant Biosciences, Inc.. [1001721163] [25-115] John Beisner [Entered: 02/14/2025 10:17 AM] |
|
Filing 19
ORDER filed granting Motion to extend filing time for response to petition [ # 16 ] Number of days granted: 21. [ # 7 ] Response due 03/17/2025. Copies to all parties. Mailed to: Michelle Blauner, Lydia Ferrarese, Edward Haber, Zachary Martin, Ian McLoughlin, Patrick Vallely, Mark Weissman. [1001720631] [25-115] DL [Entered: 02/13/2025 12:14 PM]
|
| Filing 18 (ENTRY RESTRICTED) APPEARANCE OF COUNSEL by Amanda Bird-Johnson for VSL Pharmaceuticals, Inc.. [1001720379] [25-115]--[Edited 02/14/2025 by CH] Turner Broughton [Entered: 02/13/2025 09:17 AM] |
| Filing 17 APPEARANCE OF COUNSEL by Turner A. Broughton for VSL Pharmaceuticals, Inc.. [1001720378] [25-115] Turner Broughton [Entered: 02/13/2025 09:16 AM] |
| Filing 16 MOTION by Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr and James Tettenhorst to extend filing time for TO FILE ANSWER TO PETITION FOR PERMISSION TO APPEAL until March 17, 2025.. Date and method of service: 02/12/2025 ecf. [1001720325] [25-115] Jeffrey Gavenman [Entered: 02/12/2025 08:07 PM] |
| Filing 15 DISCLOSURE STATEMENT by Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst. Was any question on Disclosure Form answered yes? No [1001720324] [25-115] Jeffrey Gavenman [Entered: 02/12/2025 07:47 PM] |
| Filing 14 APPEARANCE OF COUNSEL by Jeffrey S. Gavenman for Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst. [1001720323] [25-115] Jeffrey Gavenman [Entered: 02/12/2025 07:41 PM] |
| Filing 13 APPEARANCE OF COUNSEL by Jeremy W. Schulman for Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst. [1001720322] [25-115] Jeremy Schulman [Entered: 02/12/2025 07:38 PM] |
|
Filing 12
ORDER filed sealing the petition for permission to appeal and the appendix to petition for permission to appeal. Copies to all parties. Mailed to: Michelle Blauner, Lydia Ferrarese, Edward Haber, Zachary Martin, Ian McLoughlin, Patrick Vallely, Mark Weissman. [1001720230] [25-115] CH [Entered: 02/12/2025 04:11 PM]
|
| Filing 11 Docket correction requested from Alfasigma USA, Inc., Leadiant Biosciences, Inc. and VSL Pharmaceuticals, Inc. re: sealed version of petition for permission to appeal. [1001720203] [25-115] CH [Entered: 02/12/2025 03:57 PM] |
| Filing 9 DISCLOSURE STATEMENT by VSL Pharmaceuticals, Inc.. Was any question on Disclosure Form answered yes? Yes [1001720150] [25-115] Turner Broughton [Entered: 02/12/2025 03:21 PM] |
| Filing 8 DISCLOSURE STATEMENT by Leadiant Biosciences, Inc.. Was any question on Disclosure Form answered yes? Yes [1001720083] [25-115] John Beisner [Entered: 02/12/2025 02:52 PM] |
| Filing 7 RULE 5 NOTICE issued to Heather Farkas, Jeremy Hansen, Krista Karo, Bernadette Mavrikos, Edmund Quiambao, Arlene Reed-Cossairt, David Starr, Peter Stavros and James Tettenhorst requesting response to petition. Mailed to: Michelle Blauner, Lydia Ferrarese, Edward Haber, Zachary Martin, Ian McLoughlin, Patrick Vallely, Mark Weissman. [1001720076] [25-115] CH [Entered: 02/12/2025 02:47 PM] |
| Filing 6 DISCLOSURE STATEMENT by Alfasigma USA, Inc. Was any question on Disclosure Form answered yes? Yes. [1001720059] [25-115] CH [Entered: 02/12/2025 02:37 PM] |
| Filing 5 CERTIFICATE OF CONFIDENTIALITY (Local Rule 25(c)) by Alfasigma USA, Inc., Leadiant Biosciences, Inc. and VSL Pharmaceuticals, Inc. Sealing Required: Yes. Description of document referenced by certificate: unredacted version of petition for permission to appeal and appendix. [1001720058] [25-115] CH [Entered: 02/12/2025 02:36 PM] |
| Filing 4 SEALED DOCUMENT (court access only) by Alfasigma USA, Inc., Leadiant Biosciences, Inc. and VSL Pharmaceuticals, Inc. Document type: OTHER DOCUMENT - Appendix to Petition for Permission to Appeal . Date and manner of service: 02/12/2025 US mail. Filed Ex parte: N. [1001720050] [25-115] CH [Entered: 02/12/2025 02:29 PM] |
| Filing 3 SEALED DOCUMENT (court access only) by Alfasigma USA, Inc., Leadiant Biosciences, Inc. and VSL Pharmaceuticals, Inc. Document type: OTHER DOCUMENT - Petition for Permission to Appeal. Date and manner of service: 02/12/2025 ecf. Filed Ex parte: N. [1001720031] [25-115] CH [Entered: 02/12/2025 02:21 PM] |
| Filing 2 Petition for permission to appeal filed by Alfasigma USA, Inc., Leadiant Biosciences, Inc. and VSL Pharmaceuticals, Inc. [1001720028] [25-115] CH [Entered: 02/12/2025 02:19 PM] |
| Filing 1 Permission to appeal case docketed. Originating case number: 8:19-cv-02173-LKG. Case manager: CHalupa. [1001720010] [25-115] CH [Entered: 02/12/2025 02:04 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
